The R36 GT-R won’t just be an evolution—it’ll be a reimagination of Nissan’s most famous nameplate. Hybridized for the future, turbocharged for today, and engineered for enthusiasts, it promises to ...

Carbon fiber is renowned for its exceptional strength-to-weight ratio, making it an indispensable material in high-performance automotive applications. From supercars to electric vehicles (EVs), it ...

Luna Snow, a dynamic Strategist in Marvel Rivals, seamlessly blends healing prowess with offensive capabilities. Her unique abilities allow her to support teammates while also holding her own in ...

Adam Warlock falls under the Strategist class. This means he’s best utilized as a backline support, focusing on healing and ...

The base model of the Nintendo Switch 2 is priced at $449.99. For those interested in additional content, a bundle including ...

The latest round of US export controls specifically targets Nvidia’s H20 chips, which had been the most advanced processors that Chinese companies could still legally purchase after previous ...

Elon Musk, the world’s richest man and CEO of Tesla and SpaceX, has announced plans to visit India later this year following a teleconference with Prime Minister Narendra Modi. Musk’s X post was made ...

With this bridge round, Wow! Momo has now raised over INR 600 crore to date, solidifying its status as one of India’s most well-funded QSR startups. The company’s next major fundraising round, ...

To Zopper’s credit, it has seen strong top-line growth. Its operating revenue soared from INR 162.4 Cr in FY23 to INR 438.7 ...

The 23andMe case is not just about one company in financial trouble. It raises broader questions about the future of genetic privacy in a rapidly digitizing world. Direct-to-consumer DNA services ...

Back in 2016, Tesla painted a futuristic vision of cars that could drive themselves, even without anyone in the driver’s seat. Elon Musk stood behind the claim that all cars made from that year onward ...

The biotech industry is facing a major hurdle as widespread layoffs at the U.S. Food and Drug Administration (FDA) disrupt the drug development process. Biotech firms—particularly smaller ones—are ...